Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice
2012
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
12
References
7
Citations
NaN
KQI